Natasa Gisev

4.0k total citations · 3 hit papers
90 papers, 2.8k citations indexed

About

Natasa Gisev is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Epidemiology. According to data from OpenAlex, Natasa Gisev has authored 90 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Public Health, Environmental and Occupational Health, 33 papers in Anesthesiology and Pain Medicine and 29 papers in Epidemiology. Recurrent topics in Natasa Gisev's work include Opioid Use Disorder Treatment (65 papers), Pain Management and Opioid Use (33 papers) and Substance Abuse Treatment and Outcomes (27 papers). Natasa Gisev is often cited by papers focused on Opioid Use Disorder Treatment (65 papers), Pain Management and Opioid Use (33 papers) and Substance Abuse Treatment and Outcomes (27 papers). Natasa Gisev collaborates with scholars based in Australia, United States and United Kingdom. Natasa Gisev's co-authors include Louisa Degenhardt, J. Simon Bell, Timothy F. Chen, Suzanne Nielsen, Bianca Hoban, Timothy Dobbins, Sarah Larney, Lucy Burns, Michael Farrell and Briony Larance and has published in prestigious journals such as The Lancet, Pain and Anesthesia & Analgesia.

In The Last Decade

Natasa Gisev

86 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interrater agreement and interrater reliability: Key concepts, approaches, and applications

2012 584 citations Natasa Gisev, J. Simon Bell et al. Research in Social and Administrative Pharmacy profile →
A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

2015 408 citations Suzanne Nielsen, Louisa Degenhardt et al. Pharmacoepidemiology and Drug Safety profile →
New psychoactive substances: challenges for drug surveillance, control, and public health responses

2019 216 citations Amy Peacock, Raimondo Bruno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natasa Gisev Australia	22	1.4k	692	670	497	377	90	2.8k
Feijun Luo United States	22	1.3k 0.9×	563 0.8×	414 0.6×	385 0.8×	278 0.7×	36	2.9k
Yuhua Bao United States	29	1.2k 0.9×	506 0.7×	299 0.4×	541 1.1×	149 0.4×	112	3.1k
Curtis Florence United States	33	1.6k 1.2×	714 1.0×	332 0.5×	662 1.3×	429 1.1×	74	5.8k
John R. M. Caplehorn Australia	24	1.1k 0.8×	1.2k 1.7×	180 0.3×	275 0.6×	177 0.5×	38	2.8k
Susan Okie United States	22	725 0.5×	581 0.8×	303 0.5×	186 0.4×	183 0.5×	42	2.5k
Grant Baldwin United States	33	4.4k 3.2×	2.1k 3.0×	1.5k 2.2×	1.2k 2.5×	590 1.6×	78	6.7k
Joshua D. Brown United States	29	490 0.4×	338 0.5×	87 0.1×	282 0.6×	330 0.9×	183	2.8k
Brittany B. Dennis Canada	29	897 0.7×	1000 1.4×	147 0.2×	287 0.6×	314 0.8×	105	3.2k
Susan M. Shortreed United States	30	699 0.5×	409 0.6×	245 0.4×	178 0.4×	150 0.4×	120	3.1k
Siamak Noorbaloochi United States	29	770 0.6×	505 0.7×	298 0.4×	168 0.3×	317 0.8×	98	4.1k

Countries citing papers authored by Natasa Gisev

Since Specialization

Citations

This map shows the geographic impact of Natasa Gisev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasa Gisev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasa Gisev more than expected).

Fields of papers citing papers by Natasa Gisev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasa Gisev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasa Gisev. The network helps show where Natasa Gisev may publish in the future.

Co-authorship network of co-authors of Natasa Gisev

This figure shows the co-authorship network connecting the top 25 collaborators of Natasa Gisev. A scholar is included among the top collaborators of Natasa Gisev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasa Gisev. Natasa Gisev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zoëga, Helga, Michael O. Falster, M. Gillies, et al.. (2024). The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and Drug Safety. 33(8). e5887–e5887. 1 indexed citations

Bharat, Chrianna, Louisa Degenhardt, Amy Peacock, et al.. (2024). Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019. Social Psychiatry and Psychiatric Epidemiology. 60(3). 693–703. 1 indexed citations

Koch, Forrest, Jake Olivier, Jonathan Brett, et al.. (2024). The impact of tightened prescribing restrictions for PBS‐subsidised opioid medicines and the introduction of half‐pack sizes, Australia, 2020–21: an interrupted time series analysis. The Medical Journal of Australia. 220(6). 315–322. 6 indexed citations

Leung, Janni, Vivian Chiu, Nicola Man, et al.. (2023). All‐cause and cause‐specific mortality in individuals with an alcohol‐related emergency or hospital inpatient presentation: A retrospective data linkage cohort study. Addiction. 118(9). 1751–1762. 5 indexed citations

Colledge‐Frisby, Samantha, N. R. Jones, Louisa Degenhardt, et al.. (2023). Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study. Drug and Alcohol Dependence. 246. 109851–109851. 9 indexed citations

Varney, Bianca, Helga Zoëga, M. Gillies, et al.. (2023). Prevalence and Persistence of Prescription Opioid Use Following Hospital Discharge After Childbirth: An Australian Population-Based Cohort Study. Anesthesia & Analgesia. 138(5). 970–979.

Gisev, Natasa, Luke Buizen, Andrea L. Schaffer, et al.. (2023). Five-Year Trajectories of Prescription Opioid Use. JAMA Network Open. 6(8). e2328159–e2328159. 8 indexed citations

Bharat, Chrianna, Natasa Gisev, Sebastiano Barbieri, et al.. (2023). Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality. International Journal of Drug Policy. 123. 104287–104287. 3 indexed citations

Tesfaye, Wubshet, Ines Krass, Kamal Sud, et al.. (2023). Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol. BMJ Open. 13(12). e079110–e079110. 1 indexed citations

10.

Costa, Juliana de Oliveira, Navya Baranwal, Natasa Gisev, et al.. (2021). Variations in Long‐term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000‐2019). British Journal of Clinical Pharmacology. 87(10). 3706–3720. 8 indexed citations

11.

Pearson, Sallie‐Anne, Nicholas A. Buckley, Emily A. Karanges, et al.. (2021). Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015). Drug and Alcohol Review. 41(2). 435–443. 6 indexed citations

12.

Bharat, Chrianna, Sarah Larney, Sebastiano Barbieri, et al.. (2021). The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study. Addiction. 116(11). 3139–3152. 20 indexed citations

13.

Lalic, Samanta, J. Simon Bell, Hanna Gyllensten, et al.. (2019). Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: a 10-year population-based study. Pain. 160(5). 1224–1233. 9 indexed citations

14.

Peacock, Amy, Vivian Chiu, Janni Leung, et al.. (2019). Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data. BMJ Open. 9(8). e030605–e030605. 9 indexed citations

15.

Roxburgh, Amanda, Wayne Hall, Timothy Dobbins, et al.. (2017). Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence. 179. 291–298. 130 indexed citations

16.

Gisev, Natasa, Briony Larance, Elena Cama, et al.. (2017). A nationwide study of the extent and factors associated with fentanyl use in Australia. Research in Social and Administrative Pharmacy. 14(3). 303–308. 9 indexed citations

17.

Nielsen, Suzanne, Louisa Degenhardt, Bianca Hoban, & Natasa Gisev. (2015). A synthesis of oral morphine equivalents (OME) for opioid utilisation studies. Pharmacoepidemiology and Drug Safety. 25(6). 733–737. 408 indexed citations breakdown →

18.

Gisev, Natasa, Amy Gibson, Sarah Larney, et al.. (2014). Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians. BMC Public Health. 14(1). 920–920. 12 indexed citations

19.

Degenhardt, Louisa, Sarah Larney, Natasa Gisev, et al.. (2013). Imprisonment of opioid‐dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study. Australian and New Zealand Journal of Public Health. 38(2). 165–170. 14 indexed citations

20.

Chen, Timothy F., et al.. (2009). Mind games: Pharmacists and mental health. 90(1069). 70–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact